Crispr Therapeutics Stock Forecast

Sell candidate since Jun 05, 2026

The CRISPR Therapeutics stock price fell by -8.97% on the last day (Friday, 5th Jun 2026) from $56.95 to $51.84. During the last trading day the stock fluctuated 9.01% from a day low at $51.15 to a day high of $55.76. The price has risen in 6 of the last 10 days and is up by 3.89% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -3 million shares and in total, 0 shares were bought and sold for approximately $0 .

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 6.08% during the next 3 months and, with a 90% probability hold a price between $49.86 and $66.08 at the end of this 3-month period.

CRSP Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The CRISPR Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $54.23 and $52.74. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, June 04, 2026, and so far it has fallen -8.97%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for CRISPR Therapeutics stock

CRISPR Therapeutics finds support from accumulated volume at $49.93 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $4.61 between high and low, or 9.01%. For the last week the stock has had daily average volatility of 6.32%

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CRSP) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect CRISPR Therapeutics AG to open at $52.92, and during the day (based on 14 day Average True Range), to move between $50.30 and $53.38, which gives a possible trading interval of +/-$3.07 (+/-6.11%) up or down from last closing price. If CRISPR Therapeutics AG takes out the full calculated possible swing range there will be an estimated 6.11% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $52.80 (1.85%) than the support at $49.93 (3.68%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is CRISPR Therapeutics AG stock A Buy?

The CRISPR Therapeutics stock holds several negative signals and despite the positive trend, we believe CRISPR Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -2.873 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $52.92 ( 2.08%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk